Introduction
We are a wholly owned subsidiary of Dr. Reddy’s laboratories. We were created in 2020 by merging all service businesses within Dr. Reddy’s to create a strong customer-centric organization. Thus, we are a young and nimble organization with more than two decades of experience.
We partner with global pharmaceutical and biotech companies to advance their molecules from laboratory to market. We offer integrated API, intermediate, and formulation services that span key starting materials, advanced intermediates, and APIs to finished products such as oral solids, sterile products, nasal solutions, etc.
At Aurigene, we live by our purpose to accelerate access to affordable and innovative medicines because 'Good Health Can’t Wait'.
We offer integrated and standalone services for discovery chemistry, biology, biotherapeutics discovery, development, and manufacturing services for clinical phase I-III programs, regulatory submission batches, and commercial manufacturing across India, the UK, and Mexico.
Our focus on scientific expertise, technology, innovation, and problem-solving, along with our strong fundamentals on sustainability, compliance, and IP security, has made us a preferred partner across many large pharma and biotech companies. We believe in fostering and nurturing long-term partnerships through our work built on speed, adaptability, clarity of communication, and collaboration.
Our Growth Journey
- Dr. Reddy’s Custom Pharmaceutical Services (CPS) was founded for contract development and manufacturing
- Dr. Reddy’s CPS became a CDMO partner for top 3 innovator pharma clients
- Aurigene Discovery Technologies Limited(ADTL) was founded to serve the discovery customer
- ADTL established long-term FTE business with a top big pharma client
- Dr. Reddy’s CPS won multi-year commercial contracts with big pharma and large CDMO clients
- Services arm of ADTL and Dr. Reddy’s CPS integrated to form Aurigene Pharmaceutical Services Limited.
- Operationalization of Biologics Discovery Services
- Operationalization of Biologics CDMO Services
- Operationalization of Biologics Discovery Services
- Operationalization of Biologics CDMO Services
- Services arm of ADTL and Dr. Reddy’s CPS integrated to form Aurigene Pharmaceutical Services Limited.
- ADTL established long-term FTE business with a top big pharma client
- Dr. Reddy’s CPS won multi-year commercial contracts with big pharma and large CDMO clients
- Dr. Reddy’s Custom Pharmaceutical Services (CPS) was founded for contract development and manufacturing
- Dr. Reddy’s CPS became a CDMO partner for top 3 innovator pharma clients
- Aurigene Discovery Technologies Limited(ADTL) was founded to serve the discovery customer
Our Leadership Team
Akhil Ravi
Chief Executive Officer
Brijesh Kumar Karnani
Chief Financial Officer
Kapil Choudhury
Global Commercial Head
PVR Bharadwaja
Head - Operations
Gayathri Ramaswamy, PhD
Head, Discovery services
Srividya Ramakrishnan, PhD
Head, CDMO DS services
Rajesh Vooturi
Head, Formulation R and D
Amit Jogi, PhD
Head, CDMO Biologics services
Our Infrastructure
R and D centers
Aurigene Pharmaceutical Services is well-equipped with laboratories from discovery to clinical phase III for NCEs and NBEs. We operate two state-of-the-art R and D centers in Bangalore and Hyderabad. Our R and D centers are equipped with 60+ modular laboratories to handle highly potent substances, peptides, oligonucleotides etc. Our facility also has an extensive analytical center of excellence in addition to special purpose labs for safety assessment studies and polymorphism studies. Our best-in-class discovery biology services are supported by AAALAC accredited vivarium, BSL-2 compliant labs, in vivo facilities, GLP and other regulatory bodies accredited toxicology labs. Our state-of-the-art preclinical evaluation safety facility has been inspected by FCPSA Netherlands, DCGI and is annually inspected by National GLP Compliance Monitoring Authority (NGCMA). Our facility has also been inspected by the US FDA and the quality systems in this facility are in accordance with NGCMA and US FDA standards.
Manufacturing facilities
We have access to cGMP manufacturing facilities in the UK, Mexico and India. We operate thousands of kilo liters of API capacities that can handle various range of chemistries from regular small molecules, peptides, potent compounds, steroids, carbohydrates and pegylated drugs. In addition, we also operate formulation manufacturing plants that can handle various dosage forms including oral solids, parenteral and topical. Our facilities are designed modularly and offer flexibility of scale, enabling efficient operations. Our manufacturing facilities are regularly inspected by regulatory agencies.
Life at Aurigene
Our employees, who are constantly striving to set new benchmarks, are at the core of our success. We hire and retain the best in class talent. We foster growth of our employees with curated learning journeys and support their aspirations to help them achieve different milestones. We encourage and support innovative ideas to help employees grow and improve their skill set. Our flagship program 'Prarambh' is designed to commence the professional journey and support an enriching scientific career. Our 'Prarambh 2022' batch is a women-only batch that is focusing on Biotherapeutics services.
We strike a good balance between work and life in order to achieve our full potential. We come together to make festivals, events and other special achievements memorable.
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Compliance : Ombudsperson Reporting
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market